Silexion Therapeutics Ltd. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Silexion Therapeutics Ltd. (SLXN) is -659782.00

According to Silexion Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is -659782.00. This represents a change of 97.66% compared to the average of -333799.56 of the last 4 quarters.

Silexion Therapeutics Ltd. (SLXN) Historical Enterprise Value (quarterly & annually)

How has SLXN Enterprise Value performed in the past?

The mean historical Enterprise Value of Silexion Therapeutics Ltd. over the last ten years is 13.06M. The current -659782.00 Enterprise Value has changed -605.38% with respect to the historical average. Over the past ten years (40 quarters), SLXN's Enterprise Value was at its highest in in the June 2022 quarter at 28.95M. The Enterprise Value was at its lowest in in the September 2025 quarter at -4906990.00.

Silexion Therapeutics Ltd. (SLXN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Silexion Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Silexion Therapeutics Ltd. (SLXN) Average Enterprise Value

How has SLXN Enterprise Value performed in the past?

The current Enterprise Value of Silexion Therapeutics Ltd. (SLXN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Silexion Therapeutics Ltd. (SLXN) Enterprise Value vs. Peers

How is SLXN’s Enterprise Value compared to its peers?

Silexion Therapeutics Ltd.’s Enterprise Value is less than Indaptus Therapeutics, Inc. (437.49M), greater than Salarius Pharmaceuticals, Inc. (-6783639.00), greater than SciSparc Ltd. (-3967616.00), greater than Lipella Pharmaceuticals Inc. (-1589378.00), less than Jasper Therapeutics, Inc. (3.26M), greater than Azitra, Inc. (-4405913.00), less than Protagenic Therapeutics, Inc. (753.66K), greater than Onconetix, Inc. (-3376974.00), less than Scinai Immunotherapeutics Ltd. (1.56M), greater than Enveric Biosciences, Inc. (-7347047.00),

Build a custom stock screener for Silexion Therapeutics Ltd. (SLXN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silexion Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Silexion Therapeutics Ltd. (SLXN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Silexion Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.